Suppr超能文献

相似文献

3
Guillain-Barré syndrome temporally associated with COVID-19 vaccines in Victoria, Australia.
Vaccine. 2022 Dec 12;40(52):7579-7585. doi: 10.1016/j.vaccine.2022.10.084. Epub 2022 Nov 7.
4
Background incidence rates of selected adverse events of special interest (AESI) to monitor the safety of COVID-19 vaccines.
Vaccine. 2023 May 22;41(22):3422-3428. doi: 10.1016/j.vaccine.2023.04.041. Epub 2023 Apr 18.
6
AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link?
J Neuroimmunol. 2021 Nov 15;360:577719. doi: 10.1016/j.jneuroim.2021.577719. Epub 2021 Sep 17.
7
Post COVID-19 vaccination Guillain-Barre syndrome: three cases.
Hum Vaccin Immunother. 2022 Nov 30;18(5):2045153. doi: 10.1080/21645515.2022.2045153. Epub 2022 Mar 3.
8
Guillain-Barre syndrome should be monitored upon mass vaccination against SARS-CoV-2.
Hum Vaccin Immunother. 2021 Sep 2;17(9):2957-2958. doi: 10.1080/21645515.2021.1922061. Epub 2021 May 25.
10
Background rates of adverse events of special interest for COVID-19 vaccine safety monitoring in the United States, 2019-2020.
Vaccine. 2023 Jan 9;41(2):333-353. doi: 10.1016/j.vaccine.2022.11.003. Epub 2022 Nov 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验